ORCHESTRA BIOMED HOLDINGS IN (OBIO)
US68572M1062 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to OBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.79. This target is 180.65% above the current price.
OBIO was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about OBIO.
In the previous month the buy percentage consensus was at a similar level.
OBIO was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-02 | Barclays | Initiate | Overweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-25 | B. Riley Securities | Initiate | Buy |
| 2024-06-12 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-01-19 | Jefferies | Initiate | Buy |
| 2023-08-11 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-09 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-15 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-02-24 | Piper Sandler | Initiate | Overweight |
| 2023-02-07 | Chardan Capital | Initiate | Buy |